In previous studies, we reported that serum concentrations of IgG4, IFN-α, and IL-33 were useful biomarkers for diagnosis of AIP/IgG4-RD and monitoring of disease activity (7). This evidence concerns the gene IL33 and autoimmune pancreatitis.